{
  "id": 3531693,
  "title": "STAT+: FDA approves new pancreatic cancer drug expected to usher in new era of treatment",
  "url": "https://urgent.news/2026/08/26/stat-fda-approves-new-pancreatic-cancer-drug-expected-to-usher-in-new",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-26T14:56:13.000Z",
  "source": {
    "name": "STAT News",
    "slug": "stat-news",
    "url": "https://www.statnews.com/2026/08/26/pancreatic-cancer-drug-rasonque-approved/"
  },
  "original_language": "en",
  "account": "On Wednesday, the Food and Drug Administration approved a groundbreaking treatment for advanced pancreatic cancer, a biotech company Revolution Medicines' drug designed to target a genetic cause of the aggressive and lethal malignancy. The drug, named daraxonib and marketed under the brand name Rasonque, marks the first therapeutic approach that addresses the genetic roots of this insidious disease.\n\nSupported by a practice-changing clinical trial, the FDA's approval was driven by promising results. Patients suffering from advanced pancreatic cancer who received Rasonque as a second-line treatment experienced a median overall survival of 13.2 months. This is a stark contrast to the 6.7 months observed in patients who received standard chemotherapy. Andrew Ko, a medical oncologist specializing in gastrointestinal cancers at the University of California, San Francisco, hailed the approval as a transformative development in the field of pancreatic cancer treatment. \"It will be transformative in the way we treat pancreas cancer,\" Ko stated, expressing gratitude for the advance in care for pancreatic cancer patients.",
  "summary": "The FDA has approved a life-extending treatment for advanced pancreatic cancer — the first such therapy to attack a genetic cause of the highly lethal malignancy.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 10,
    "also_reported_by": [
      {
        "outlet": "Endpoints News",
        "title": "FDA approves Revolution Medicines' pancreatic cancer drug",
        "url": "https://urgent.news/2026/08/26/fda-approves-revolution-medicines-pancreatic-cancer-drug",
        "published": "2026-08-26T15:15:20.000Z"
      },
      {
        "outlet": "The New York Times",
        "title": "F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer",
        "url": "https://urgent.news/2026/08/26/f-d-a-approves-the-drug-daraxonrasib-thats-poised-to-transform",
        "published": "2026-08-26T15:23:53.000Z"
      },
      {
        "outlet": "CNBC",
        "title": "Revolution Medicines gets FDA nod for targeted pancreatic cancer drug",
        "url": "https://urgent.news/2026/08/26/revolution-medicines-gets-fda-nod-for-targeted-pancreatic-cancer-drug",
        "published": "2026-08-26T15:51:05.000Z"
      },
      {
        "outlet": "Forbes",
        "title": "FDA Approves Pancreatic Cancer Drug That Could Double Survival Time",
        "url": "https://urgent.news/2026/08/26/fda-approves-pancreatic-cancer-drug-that-could-double-survival-time",
        "published": "2026-08-26T15:53:23.000Z"
      },
      {
        "outlet": "Winnipeg Free Press",
        "title": "FDA approves landmark pancreatic cancer drug that’s shown to improve survival",
        "url": "https://urgent.news/2026/08/26/fda-approves-landmark-pancreatic-cancer-drug-thats-shown-to-improve",
        "published": "2026-08-26T15:58:38.000Z"
      },
      {
        "outlet": "Scientific American",
        "title": "U.S. approves breakthrough pancreatic cancer drug, heralding a new era for an intractable disease",
        "url": "https://urgent.news/2026/08/26/u-s-approves-breakthrough-pancreatic-cancer-drug-heralding-a-new-era",
        "published": "2026-08-26T16:00:00.000Z"
      },
      {
        "outlet": "Associated Press",
        "title": "FDA approves landmark pancreatic cancer drug that’s shown to improve survival",
        "url": "https://urgent.news/2026/08/26/fda-approves-landmark-pancreatic-cancer-drug-thats-shown-to-improve-3544603",
        "published": "2026-08-26T16:23:02.000Z"
      },
      {
        "outlet": "MyJoyOnline Ghana",
        "title": "U.S. FDA approves landmark pancreatic cancer drug that’s shown to improve survival",
        "url": "https://urgent.news/2026/08/26/u-s-fda-approves-landmark-pancreatic-cancer-drug-thats-shown-to",
        "published": "2026-08-26T16:44:10.000Z"
      },
      {
        "outlet": "Guardian Health",
        "title": "FDA gives expedited approval to new groundbreaking pancreatic cancer drug",
        "url": "https://urgent.news/2026/08/26/fda-gives-expedited-approval-to-new-groundbreaking-pancreatic-cancer",
        "published": "2026-08-26T16:48:27.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}